Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Thrombocytopenia
•
Hematology
•
Pediatric Hematology
What is your approach to chronic non-immune mediated thrombocytopenia management in children?
Related Questions
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
In what clinical scenario would you consider liver transplant evaluation for a patient with sickle cell hepatopathy?
Do you routinely screen and replace Vitamin D in patients with ITP?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
Does continuous platelet transfusion reduce platelet refractoriness in ECMO?
For pediatric patients with iron overload (high ferritin and transferrin saturation), do you perform HFE screening first, or proceed to non-HFE gene sequencing upfront to evaluate for HJV mutation as well?
What is the best way to prepare children with von Willebrand disease for tonsillectomy to reduce the risk of post-operative hemorrhage?
How would you manage HHT with ongoing epistaxis despite IV bevacizumab, with a history of superficial thrombosis?
Do you recommend indefinite anticoagulation for patients with homozygous Factor V Leiden mutation who have had a provoked VTE?
What are your top takeaways in Classical Hematology from ASH 2025?
